<?xml version="1.0" encoding="UTF-8"?>
<ref id="R22">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Khamashta</surname>
    <given-names>M</given-names>
   </string-name>, 
   <string-name>
    <surname>Merrill</surname>
    <given-names>JT</given-names>
   </string-name>, 
   <string-name>
    <surname>Werth</surname>
    <given-names>VP</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study</article-title>. 
  <source>Ann Rheum Dis</source>
  <year>2016</year>;
  <volume>75</volume>:
  <fpage>1909</fpage>–
  <lpage>16</lpage>. 
  <pub-id pub-id-type="doi">10.1136/annrheumdis-2015-208562</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/27009916?>
  <pub-id pub-id-type="pmid">27009916</pub-id>
 </mixed-citation>
</ref>
